NAP1L1 and hepatocellular carcinoma: Here, we found that NAP1L1 expression was significantly upregulated in HCC as compared to the adjacent non-tumor hepatocytes, and high NAP1L1 expression was significantly associated with aggressive clinicopathologic features (i.e., serum AFP levels, larger tumor size and late clinical stage).